BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Leucine rich repeat and Ig domain containing 1 (LINGO1)

March 24, 2016 7:00 AM UTC

Patient sample and cell studies suggest anti-LINGO1 antibody-drug conjugates (ADCs) could help treat Ewing sarcoma, a cancer derived from mesenchymal stem cells. LINGO1 levels were higher in tumor sam...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article